CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
1. CVS exceeds Q2 earnings expectations and boosts annual guidance. 2. Total Q2 revenues rise 8.4% to $98.90 billion, surpassing forecasts. 3. Litigation charges impact GAAP earnings, decreasing to $0.80 per share. 4. CVS commits $20 billion over a decade to simplify healthcare. 5. Prescriptions filled increased by 4.2%, reflecting higher utilization.